2026 The Governance Gap Belongs to the Deployer, Not the Regulator Hospitals and pharma functions adopting generative AI now carry governance obligations that device and drug frameworks were never built to cover.
2026 Quantum-Classical AI Enters Drug Discovery, Validation Frameworks Don't Quantum-enhanced generative AI is moving into drug discovery pipelines faster than GxP validation and data integrity practices can absorb it.